Biography
Meg joined the lab after completing her Ph.D. in Integrative Pathobiology at the University of California, Davis, where she investigated immunothrombosis and the role of procoagulant platelets in feline hypertrophic cardiomyopathy as a translational model for human disease. Her work focused on elucidating platelet activation pathways, platelet-neutrophil interactions, and novel antiplatelet strategies targeting procoagulant phenotypes. In the Kornblith Lab, Meg is exploring procoagulant platelets in trauma and critical illness to better understand the mechanisms driving pathologic thrombosis.
Background
Meg is an incoming postdoctoral researcher in the Kornblith Lab at UCSF. She recently completed her Ph.D. in Integrative Pathobiology at UC Davis, where her research focused on immunothrombosis and procoagulant platelets in feline hypertrophic cardiomyopathy as a translational model for human thrombosis. Broadly, she is interested in studying coagulation as well as in developing strategies to prevent or treat pathologic thrombosis.